Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592137 · ClinicalTrials.gov registry record · NA
Calcium, Dairy, and Body Fat in Adolescents
A NA study of Obesity and Energy Metabolism, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT00592137: Completed NA study of Obesity and Energy Metabolism, sponsored by Purdue University.
NCT00592137 is a NA study of Obesity and Energy Metabolism that has completed, run by Purdue University. The registered enrollment target is 43 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00592137, a NA study of Obesity and Energy Metabolism, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
Lifestyle choices,including diet,are conducive to healthy body weights in children. Dairy products and calcium supplementation have been associated with moderation of body weight and body fat. This study was designed to test the following hypotheses with overweight and obese adolescents consuming a controlled diet: * Dietary calcium supplementation as calcium carbonate or dairy calcium modulates energy balance in adolescents. * Increased calcium in the diet of adolescents will increase fecal fat excretion and thereby decrease fat absorption. * Calcium and dairy product supplementation will increase lipid oxidation resulting in an increase in energy expenditure.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT C (smoothies based on soy protein containing no additional calcium)
- DIETARY_SUPPLEMENT B (smoothies based on soy protein containing calcium)
- DIETARY_SUPPLEMENT A (smoothies based on dairy protein containing calcium)
Study Locations (1)
Indiana
- Department of Foods and Nutrition - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2004-04 |
| Est. Completion | 2004-08 |
| Phase | NA |
What the finished NCT00592137 record still lists
NCT00592137 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which C (smoothies based on soy protein containing no additional calcium) is the first listed.
NCT00592137 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT00592137 about?
NCT00592137 is a clinical study titled "Calcium, Dairy, and Body Fat in Adolescents". Lifestyle choices,including diet,are conducive to healthy body weights in children. Dairy products and calcium supplementation have been associated with moderation of body weight and body fat. This study was designed to test the following hypotheses with overweight and obese adolescents consuming a ...
What is the current status of trial NCT00592137?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2004-04. Estimated completion is 2004-08.
What conditions does trial NCT00592137 study?
This clinical trial studies the following conditions: Obesity, Energy Metabolism.
What interventions are being tested in trial NCT00592137?
The interventions under investigation include: C (smoothies based on soy protein containing no additional calcium) (DIETARY_SUPPLEMENT), B (smoothies based on soy protein containing calcium) (DIETARY_SUPPLEMENT), A (smoothies based on dairy protein containing calcium) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00592137?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00592137 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00592137's enrollment target sits among peer trials
43 767th of 1053 higher than 284 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia